The influence of a polychemotherapeutic regimen on the female endocrine control mechanisms in mammary carcinoma patients.
D000328:Adult; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D004702:Endocrine Glands / Q000378:metabolism*; D005260:Female; D006728:Hormones / Q000097:blood; D006801:Humans; D007030:Hypothalamo-Hypophyseal System / Q000187:drug effects; D008593:Menopause; D008599:Menstruation Disturbances / Q000209:etiology; D008875:Middle Aged; D010053:Ovary / Q000187:drug effects
D000970:Antineoplastic Agents; D006728:Hormones